NCT02690207: A reported trial by GlaxoSmithKline
This trial has reported on time, in line with the regulations.
Full data
| Full entry on ClinicalTrials.gov | NCT02690207 |
|---|---|
| Title | Cross-vaccination Study of GSK Biologicals' Lyophilized Formulation of the Herpes Zoster Subunit (HZ/su) Vaccine (GSK 1437173A) in Subjects Who Previously Received Placebo in ZOSTER-006 (NCT01165177) and ZOSTER-022 (NCT01165229) Studies |
| Results Status | Reported |
| ACT or pACT? | This is what FDAAA officially calls a "probable Applicable Clinical Trial" |
| Start date | March 16, 2016 |
| Completion date | March 15, 2019 |
| Required reporting date | March 14, 2020, midnight |
| Actual reporting date | Feb. 26, 2020 |
| Date last checked at ClinicalTrials.gov | March 26, 2026 |
| Days late | None |